Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response (2021)
Attributed to:
Computational Genomics Analysis and Training programme (CGAT)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-0177
Publication URI: http://dx.doi.org/10.1158/0008-5472.can-20-0177
Type: Journal Article/Review
Parent Publication: Cancer Research
Issue: 7